About Us

Mylan [mī-luhn] is one of the world’s leading quality generic and specialty pharmaceutical companies. The company offers one of the industry’s broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Employing approximately 15,000 people, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global scale and a committed focus on quality and customer service.

Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to the second-largest active pharmaceutical ingredient (API) manufacturer in the world. This relationship makes Mylan one of only two global generic companies with a comprehensive, vertically integrated supply chain.

Dey L.P., Mylan’s fully integrated specialty business, provides the company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

An Established Market Leader Mylan today holds leading positions in 13 of the most competitive generics markets across the globe.*
Australia (No. 1) Belgium (No. 2) France (No. 1) Holland (No. 5) Ireland (No. 4)	Italy (No. 3) Japan (No. 4)** Portugal (No. 1) New Zealand (No. 1) Scandinavia (No. 4)	Spain (No. 3) United Kingdom (No. 2) United States (No. 2)
* as of March 15, 2008 ** largest international company